JP2024504777A5 - - Google Patents

Info

Publication number
JP2024504777A5
JP2024504777A5 JP2023545809A JP2023545809A JP2024504777A5 JP 2024504777 A5 JP2024504777 A5 JP 2024504777A5 JP 2023545809 A JP2023545809 A JP 2023545809A JP 2023545809 A JP2023545809 A JP 2023545809A JP 2024504777 A5 JP2024504777 A5 JP 2024504777A5
Authority
JP
Japan
Prior art keywords
fusion protein
subunit
nanocage
item
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023545809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504777A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/050122 external-priority patent/WO2022160057A1/en
Publication of JP2024504777A publication Critical patent/JP2024504777A/ja
Publication of JP2024504777A5 publication Critical patent/JP2024504777A5/ja
Pending legal-status Critical Current

Links

JP2023545809A 2021-01-28 2022-01-28 Multabody構築物、組成物および方法 Pending JP2024504777A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163142704P 2021-01-28 2021-01-28
US63/142,704 2021-01-28
PCT/CA2022/050122 WO2022160057A1 (en) 2021-01-28 2022-01-28 Multabody constructs, compositions, and methods

Publications (2)

Publication Number Publication Date
JP2024504777A JP2024504777A (ja) 2024-02-01
JP2024504777A5 true JP2024504777A5 (https=) 2025-02-04

Family

ID=82652697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023545809A Pending JP2024504777A (ja) 2021-01-28 2022-01-28 Multabody構築物、組成物および方法

Country Status (9)

Country Link
US (1) US20240317842A1 (https=)
EP (1) EP4284840A4 (https=)
JP (1) JP2024504777A (https=)
KR (1) KR20230136166A (https=)
CN (1) CN117157328A (https=)
AU (1) AU2022212978A1 (https=)
CA (1) CA3208446A1 (https=)
MX (1) MX2023008912A (https=)
WO (1) WO2022160057A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250276070A1 (en) * 2021-07-12 2025-09-04 The Hospital For Sick Children Optimized multabody constructs, compositions, and methods
CN118488971A (zh) * 2021-09-13 2024-08-13 儿童医院 优化的Multabody构建体、组合物和方法
EP4416189A4 (en) * 2021-10-16 2025-08-27 Hospital For Sick Children MODIFIED MULTIBODY CONSTRUCTS, COMPOSITIONS AND METHODS TARGETING SARS-CoV-2
WO2023060358A1 (en) * 2021-10-16 2023-04-20 The Hospital For Sick Children Modified multabody constructs, compositions, and methods
KR20250143754A (ko) * 2022-12-18 2025-10-02 래디언트 바이오테라퓨틱스 인크. 다가 조혈 세포 인게이저 또는 활성화제
CN120771308B (zh) * 2025-09-04 2025-12-12 中山大学 一种具有缓释效应的蛋白笼纳米药物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019023811A1 (en) * 2017-08-04 2019-02-07 The Hospital For Sick Children NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY
KR20210044783A (ko) * 2018-07-11 2021-04-23 모멘타 파머슈티컬스 인코포레이티드 CTLA-4 표적화 조작된 Fc-항원 결합 도메인 작제물에 관련된 조성물 및 방법
AU2020320459A1 (en) * 2019-08-01 2022-03-03 The Governing Council Of The University Of Toronto Multi-valent and multi-specific nanoparticle platforms and methods
EP4225804A4 (en) * 2020-10-09 2025-07-02 Hospital For Sick Children POLYPEPTIDES TARGETING SARS-CoV-2, COMPOSITIONS AND RELATED METHODS

Similar Documents

Publication Publication Date Title
JP2024504777A5 (https=)
JP7328267B2 (ja) Hiv感染症の予防または処置のための三重特異性および/または三価結合タンパク質
US20230357401A1 (en) Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use for treating viral infection
JP6104121B2 (ja) 操作されたヘテロ二量体タンパク質ドメイン
US10280215B2 (en) Anti-C5 antibodies and methods of treating complement-related diseases
JP2019519527A (ja) 操作されたFcコンストラクトに関する組成物及び方法
RU2015145719A (ru) Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения
EA038407B1 (ru) Связывающие молекулы, направленные против гемагглютинина вируса гриппа, и пути их применения
JP2017523814A5 (https=)
CN106661125A (zh) 涉及工程化Fc构建体的组合物和方法
JP2023544211A5 (https=)
CA3232349A1 (en) Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof
CN110234355A (zh) 单体人IgG1 Fc和双特异性抗体
EP3288974B1 (en) Type iii secretion system targeting molecules
JP2024504777A (ja) Multabody構築物、組成物および方法
JP2021512159A5 (https=)
JP7676316B2 (ja) Hiv感染症の処置のためのクロスオーバー二重可変ドメイン(codv)フォーマットを使用した三重特異性および/または三価結合性タンパク質
BR112019013955A2 (pt) Composições e métodos relacionados a construtos de fc manipulados
JP2024541905A (ja) 人工操作Fcバリアント
JP2023550191A5 (https=)
US20220144956A1 (en) HETERODIMERIC ANTIBODIES THAT BIND TGFbetaRII
US20250197481A1 (en) Antigen Binding Polypeptides, Antigen Binding Polypeptide Complexes and Methods of Use Thereof in HIV
US20130189247A1 (en) Multimeric Proteins Comprising Immunoglobulin Constant Domains
Wang et al. New directions for half-life extension of protein therapeutics: the rise of antibody Fc domains and fragments
US20260098090A1 (en) Fusions with cd8 antigen binding molecules for treating chronic viral infection